glp1-gi-ae-pharmacological-rescue

name

glp1-gi-ae-pharmacological-rescue

description

Select the right rescue medication for GI adverse events caused by a GLP-1 receptor agonist — antiemetics for nausea/vomiting, antidiarrhoeals for diarrhoea, stool softeners for constipation, plus drug-interaction adjustments. Use when a clinician asks "which antiemetic on semaglutide", "domperidone vs metoclopramide for GLP-1 nausea", "loperamide for liraglutide diarrhoea", or asks for pharmacological rescue when diet/lifestyle alone has failed. Grounded in Gorgojo-Martínez 2023 §4.3 and Figure 4.

GLP-1 GI AE — Pharmacological Rescue Selector

Purpose

When non-pharmacological measures fail to control GI AEs, pick the right rescue agent — with the correct dose, special population caveats, and the critical 30-min gap rule for oral semaglutide. Pharmacology is short-term support; it is not a substitute for dose adjustment.

Activation

Trigger when:

• Diet/lifestyle measures from glp1-gi-ae-symptom-advisor are insufficient.
• Clinician asks which drug to add for a specific GLP-1-induced GI symptom.

Selectors by Symptom

Nausea

• First line: Domperidone 10–20 mg PO 3–4 times daily.
• Why over metoclopramide: lower extrapyramidal side-effect risk, especially in older patients.
• Avoid in: children < 12 y.
• Alternative: Cinitapride (substituted benzamide) if domperidone unavailable/unsuitable.
• Prokinetic role: also helps if delayed gastric emptying is the dominant mechanism.

Vomiting

• Same first-line: Domperidone (preferred over metoclopramide).
• If severity + dehydration signs (dizziness, confusion, fatigue) → standard severe-vomiting protocol; do NOT rule out IV rehydration.
• If antiemetic + hydration insufficient → dose reduction or temporary GLP-1 hold.

Diarrhoea

• Loperamide as first-line antidiarrhoeal.
• Consider probiotics as adjunct.
• Drug interaction check: if patient on metformin (especially with omeprazole) → reduce metformin dose; metformin commonly amplifies GLP-1 diarrhoea.

Constipation

• Stool softeners first-line.
• If persistent → consider GLP-1 dose reduction.
• Also reinforce fibre + hydration + activity (glp1-gi-ae-symptom-advisor).

CRITICAL Drug-Drug Rule — Oral Semaglutide (Rybelsus)

If the GLP-1 RA is oral semaglutide, any concomitant oral rescue medication (domperidone, loperamide, etc.) MUST be separated by at least 30 minutes from the semaglutide dose. Otherwise absorption is wrecked. This is non-negotiable.

Duration Rule

If a rescue drug is needed for > 1 month after the maintenance GLP-1 dose has been reached → the GLP-1 dose should be reduced rather than perpetually masking AEs with antiemetics/antidiarrhoeals.

Pancreatobiliary Caveat (linked skill)

If the patient has a history of cholelithiasis → consider ursodeoxycholic acid prophylaxis. Lipase/amylase elevations up to 3–5× ULN are common and are poor predictors of acute pancreatitis. See glp1-pancreatobiliary-risk-monitor.

Rules & Constraints

1. Domperidone over metoclopramide — always, unless contraindicated.
2. No metoclopramide first-line — extrapyramidal risk.
3. Pharmacology is bridge therapy, not destination — > 1 month means dose reduction.
4. Always check the metformin co-prescription for diarrhoea cases.
5. Oral semaglutide → 30-min gap for every co-administered oral drug.
6. No new prescription without confirming the patient is already adherent to dietary measures (otherwise just adding pills).

Reference

Gorgojo-Martínez JJ et al. J Clin Med 2023;12:145. §4.3, Figure 4.